Intravenous L- Carnitine in HD patients and some of its benefits: A single-center Observation

Abir Farouk Megahed *

Nephrology Consultant in Arar Hospital, MOH Nephrology Administration, Mansoura military hospital-nephrology department, 12 Hedaya st. Mubarek City, Mansoura, Daqahlia, Egypt.

Ghassoub Mustafa Hles

Teshrin University Nephrology specialist in Arar Hospital, Egypt.

Amany S. Elbahnasawy

Rheumatology and Rehabilitation Mansoura University, Egypt.

Nagy Sayed-Ahmed

Nephrology and Internal Medicine. Nephrology and Dialysis Unit (MNDU), Faculty of Medicine, Mansoura University, Mansoura, Egypt.

*Author to whom correspondence should be addressed.


Abstract

 

The “Type of Article” of this paper is “Letter to the Editor”. This paper discuses about: “Intravenous L- Carnitine in HD patients and some of its benefits: A single-center Observation”. No formal abstract is available. Readers are requested to read the full article.


How to Cite

Megahed, Abir Farouk, Ghassoub Mustafa Hles, Amany S. Elbahnasawy, and Nagy Sayed-Ahmed. 2021. “Intravenous L- Carnitine in HD Patients and Some of Its Benefits: A Single-Center Observation”. Asian Journal of Medicine and Health 19 (7):92-95. https://doi.org/10.9734/ajmah/2021/v19i730347.

Downloads

Download data is not yet available.